Friends who are engaged in scientific research probably have encountered this situation: the research has been done almost, and when I read the page fee when I post an article, it hurts a little in an instant.

　　But don’t worry, today I will dig through those reliable “treasure journals” for you! Whether you are engaged in basic medicine, clinical medicine, or pharmacy research, you can find a suitable "stage" here to make the results appear, and your wallet won't have to bleeding heavily~

　　01

　　Journal of Biomedical Science

　　

　　Journal official website:

　　http://jbiomedsci.biomedcentral.com

　　ISSN: 1021-7770

　　Journal Division: JCR District 1, Major Medical Journals of the Chinese Academy of Sciences

　　Influencing factors: 12.1

　　Early warning record: None

　　Self-induced quotient rate: 0.8%

　　Journal of Biomedical Science was founded in 1994 and transferred to BMC for publication in 2009. It is a bimonthly magazine supported by the National Science and Technology Commission (NSTC) in Taiwan.

　　As an open-access peer-reviewed journal, it covers basic and molecular research in basic medicine, focuses on biomedical issues and molecular mechanisms, and covers multiple fields such as anatomical pathology, biochemistry, and genetics.

　　Although the impact factors of this journal have fluctuations, the overall trend is on the rise. In addition, NSTC bears the layout fee and there is no pressure on authors to pay. Friends with limited financial support can try it!

　　In the past three years, 96 articles have been published annually, 22% of which come from Taiwan, China, followed by the United States and mainland China, and the issuing units are concentrated in universities on the island of Taiwan.

　　

　　The official website shows that the review efficiency is high, with the first decision cycle of 19 days, and the submission to acceptance is about 154 days. According to netizens, the acceptance rate of the latest news of the journal has decreased, only 3%. Friends who are anxious to publish articles make careful choices!

　　Submission experience:

　　1. Research direction: Medicine, Urology and Nephrology

　　This magazine is very good and has a fast review speed. Last week, I submitted the article and gave it news in the second week. The external review only gave it for one month. Although the article was rejected in the end, the experts gave very good suggestions and hope to continue working hard and submit it next time!

　　2. Research direction: Medicine Cell Biology

　　A more serious research direction: sharing of experience in cancer biology: I received a research article before, with a moderate speed, and it was submitted for about 3 weeks for review, and four or five weeks for draft review, so the results will be returned in about two months each round. The editor is more responsible and any minor issues are submitted for review, so I have experienced 4 rounds of review. 105 articles were issued in 2024, with a total of 6,000 submissions, and the submission rate was relatively low. If you want to quickly invest in hydrology, be careful.

　　3. Research direction: Medicine Medicine: Research and Experiment

　　Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: February 27, 2025 - Submission February 28, 2025 - Transfer to editor for processing March 17, 2025 - Received an email rejection and notified that only 3% of the manuscripts will be submitted for review.

　　02

　　Military Medical Research

　　

　　Journal official website:

　　https://www.springer.com/journal/40779

　　ISSN: 2095-7467

　　Journal Division: JCR District 1, Major Medical Journals of the Chinese Academy of Sciences District 1 TOP

　　Influencing factor: 22.9

　　Early warning record: None

　　Self-induced quotient rate: 3.60%

　　"Cancer Communications" was founded in 2014 and sponsored by the People's Military Medical Press and published by Springer Nature-BMC. It is an open-access, peer-reviewed journal that mainly publishes cutting-edge results in the fields of basic medicine and clinical research related to military medicine.

　　The scope of the receipt is mainly concentrated in the field of military medicine, including trauma and war surgery, disaster medicine, infectious disease prevention and control, CBRN (chemistry, biology, radiation, nuclear) medical countermeasures, environmental medicine (such as battlefield, extreme environment), aerospace and marine medicine, military training medicine, etc.

　　This magazine was generally on an upward trend, with the highest impact factor reaching 34.915, and the self-citation rate remained at a low level, indicating that the quality of the article is relatively reliable and has no moisture. It is considered a very substantial journal.

　　In recent years, the number of publications in this journal has been between 50 and 60, and the proportion of publications in Chinese people accounts for nearly 50%. The 2024 review cycle data released by the journal's official website is: the editor's initial review cycle is about 5 days, and the median review from the submission to the final acceptance of the article is about 201 days, and the layout fee is borne by the Chinese People's Military Medical Publishing House.

　　

　　Submission experience:

　　1. Research direction: Urology

　　Review speed: 2.0 | Submission hit rate: 25.0 The review speed is not slow, the reviewer's opinion is pertinent, regardless of whether it is a good match, it is worth trying.

　　2. Research direction: Medicine Public health, environmental sanitation and occupational sanitation

　　2024.7.24 new submission

　　2024.7.28 Editor Assigned

　　2024.7.30 reject

　　03

　　Asian Journal of Pharmaceutical Sciences

　　

　　Journal official website:

　　http://www.journals.elsevier.com/asian-journal-of-pharmaceutical-sciences/

　　ISSN: 1818-0876

　　Journal Division: JCR District 1, Major Medical Journals of the Chinese Academy of Sciences District 1 TOP

　　Influencing factors: 11.9

　　Early warning record: None

　　Self-induced quotient rate: 1.70%

　　"Asian Journal of Pharmaceutical Sciences" is an official journal of the Asian Pharmaceutical Association (AFPS), and is a full-language bimonthly magazine sponsored by Chenyang Pharmaceutical University and jointly published by Elsevier.

　　The journal covers research in all aspects of pharmacy, including drug release systems, drug targeting, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceuticals, drug and prodrug design, drug analysis, drug stability, quality control, drug engineering and materials science.

　　The journal only had its first impact factor in 2017. Since then, the score has been on an upward trend and the self-citation rate has always been within the safe range. Overall, the prospects of this journal are still very good.

　　In recent years, the number of posts in the magazine has been around 60, and the number of posts is at a relatively low level. However, the proportion of posts by Chinese people is as high as 67%. In addition, there is no page fee, so please feel free to invest!

　　

　　Submission experience:

　　1. The publication volume is not large and the speed is too slow. The submission is still in the same state as an editor for one month. The quality of the article is average, but it is not easy to think about it.

　　2. It took about 1 year to receive it. It was during the epidemic. I don’t know if it will be faster now. The reviewer’s opinions are still very professional. The editor’s processing speed is a bit slow, but the overall responsibility is still relatively fast. The communication is also very fast. The above said that there is no hard backend that you can’t invest, so it won’t be that I was reviewed by JCR for re-investment. Because the epidemic cannot make up for experiments, I am very anxious to graduate and other things. There are still risks. However, the time is mainly spent on 1 repair. 2 repairs and posting after receiving are extremely fast. There is no need for the page fee. It is still cost-effective.

　　04

　　Chinese Medical Journal

　　

　　Journal official website: http://www.cmj.org/

　　ISSN: 0366-6999

　　Journal Division: JCR Q1, Chinese Academy of Sciences Medical Journal District 2

　　Influencing factor: 7.3

　　Early warning record: None

　　Self-induced quotient rate: 4.10%

　　Chinese Medical Journal is a peer-reviewed online journal, a bimonthly. Mainly reports on all technical and clinical research related to health, ethical and social issues in the field of medical research. Articles with clinical interest and impact will be given priority. Specific topics include Helicobacter pylori, microbiota and cancer, diabetes, progress and challenges in cancer treatment, Alzheimer's disease, gut flora, cardiology, tumor epidemiology and public health, HIV/AIDS, important coronaviruses, etc.

　　"Chinese Medical Journal" is the official journal of the Chinese Medical Association (CMA). It was founded in 1887 and is currently published in a semi-monthly form by the Lippincott platform under Wolters Kluwer.

　　This journal is committed to reporting technical and clinical research related to health, ethical and social issues in the field of medical research, and pays particular attention to research results with clinical application value and wide impact. The impact factor has been increasing year by year, and the self-citation rate has always been within the safe range. It is undoubtedly a high-quality journal.

　　In recent years, the number of publications has declined. In 2024, 213 publications were published, accounting for more than 90% of Chinese people’s publications, and the admission rate is as high as 55%. The probability of investing in China is high, which is relatively easy for domestic researchers to publish articles.

　　

　　Submission experience:

　　1.2023-08-03 Submission

　　2024-01-21 Officially accepted

　　2024-04-02 online

　　2024-05-05 Officially published

　　The overall speed of high-quality domestic medical journals is relatively slow. The waiting time for a single re-repair starts at least 1 month, whether it is a major or minor revision. The review process is also relatively rigorous and complex, and statistical proof is required. After receiving, the draft will be proofreaded many times before the paper version will be released. The manuscript has a wide range of scope. You can try it as long as it is related to medicine. The quality of the article is generally high. If you are not in a hurry, it is worth recommending!

　　2. Review speed: 12.0 research direction: tumor experience sharing: 2024.8.29 submission, after more than a month, from with editor to under review, 2025.3 is still under review status, emails urge the magazine to change its status, 2025.3 rejected the manuscript, 7 reviewers had 5 pages of opinions, only one reviewer refused, but the result was rejection. A submission with super poor somatosensory feeling

　　Summarize

　　These domestic journals that do not require a layout fee do indeed provide researchers with limited scientific research funds with affordable and high-quality choices. They perform well in academic indicators such as JCR zoning and impact factors, covering multiple fields such as basic medicine, military medicine, pharmacy, and clinical medicine, and are also more "friendly" to local research results.

　　However, you must also consider calmly when selecting a journal: for example, some journals have low acceptance rate and long review cycle, while others have specific scope of acceptance, and they must also match them with their own research direction, maturity of results and time planning.

　　I hope this information can help you narrow your choices and find a truly suitable submission platform. I wish every solid research can be published successfully~